Poster No:
373
Submission Type:
Abstract Submission
Authors:
Yushu Zhou1,2,3, Xuzhen Liu1,2,3, Kang Liu1,2,3, Xue Li1,2,3, song liu1,2,3, Anran Chen1,2,3, Weiyi Han1,2,3, Xiaoyue Duan1,2,3, Wenqiang Li1,2,3, Luxian Lv1,2,3, Yongfeng Yang1,2,3
Institutions:
1Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China, 2Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan, Xinxiang, China, 3Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder, Xinxiang, China
First Author:
Yushu Zhou
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Co-Author(s):
Xuzhen Liu
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Kang Liu
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Xue Li
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
song liu
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Anran Chen
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Weiyi Han
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Xiaoyue Duan
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Wenqiang Li
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Luxian Lv
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Yongfeng Yang
Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University|Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan|Henan Collaborative Innovation Center of Prevention and Treatment of Mental Disorder
Xinxiang, China|Xinxiang, China|Xinxiang, China
Introduction:
Schizophrenia (SZ) presents with a variety of clinical symptoms, and the treatment and prognosis differ between patients with prominent positive symptoms and those with prominent negative symptoms. However, there is a lack of research on the pathological mechanisms underlying the brain differences between SZ with prominent positive symptoms, SZ with prominent negative symptoms, and healthy controls (HC). In this study, we used amplitude of low-frequency fluctuations (ALFF), fractional amplitude of low-frequency fluctuations (fALFF), regional homogeneity (ReHo), and functional connectivity (FC) for analysis, aiming to compare the functional differences in brain regions among the three groups of subjects and to explore the imaging mechanisms behind the occurrence of different symptoms in SZ.
Methods:
This study recruited 38 HC, 38 SZ with prominent negative symptoms(SZ-Ⅰ), and 39 SZ with prominent positive symptoms(SZ-Ⅱ) from the Second Affiliated Hospital of Xinxiang Medical University and surrounding communities. Data were preprocessed using dpabi, and single-factor analysis of variance with SPM(Statistical Parametric Mapping) was performed to compare ALFF, fALFF, and ReHo values among the three groups to identify brain regions with differences. Based on the brain regions that showed differences across all three groups, we calculated FC to the whole brain at the voxel level and used single-factor ANOVA to compare FC among the three groups, further analyzing the correlation between the functions of the differential brain regions and cognitive functions.
Results:
The fALFF values in the right caudate nucleus of SZ-Ⅰ were significantly higher than those of HC, and those of SZ-Ⅱ were significantly higher than those with prominent negative symptoms, with significant differences observed among all three groups (FDR corrected, F=20.2428). The ReHo values in the right caudate nucleus also showed differences among the three groups (FDR corrected, F=16.9499). In SZ-Ⅱ, there was a correlation between the fALFF values in the right caudate nucleus and the maze scores (p=0.034, r=-0.388, FDR=0.34). In SZ-Ⅰ, there was a correlation between the fALFF values in the right caudate nucleus and the spatial span scores (p=0.010, r=-0.479, FDR=0.10).
Conclusions:
The right caudate nucleus is a brain region that shows significant differences between SZ-Ⅰ, SZ-Ⅱ, and HC. The right caudate nucleus is an important imaging biomarker of SZ, and this study may provide a deeper understanding of the pathophysiological mechanisms of different subtypes of SZ.
Disorders of the Nervous System:
Psychiatric (eg. Depression, Anxiety, Schizophrenia) 1
Modeling and Analysis Methods:
fMRI Connectivity and Network Modeling 2
Novel Imaging Acquisition Methods:
BOLD fMRI
Multi-Modal Imaging
Keywords:
FUNCTIONAL MRI
Schizophrenia
Other - Positive Symptoms; Negative Symptoms; Right Caudate Nucleus
1|2Indicates the priority used for review
By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.
I accept
The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information.
Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:
I am submitting this abstract as an original work to be reproduced. I am available to be the “source party” in an upcoming team and consent to have this work listed on the OSSIG website. I agree to be contacted by OSSIG regarding the challenge and may share data used in this abstract with another team.
Please indicate below if your study was a "resting state" or "task-activation” study.
Resting state
Healthy subjects only or patients (note that patient studies may also involve healthy subjects):
Patients
Was this research conducted in the United States?
No
Were any human subjects research approved by the relevant Institutional Review Board or ethics panel?
NOTE: Any human subjects studies without IRB approval will be automatically rejected.
Yes
Were any animal research approved by the relevant IACUC or other animal research panel?
NOTE: Any animal studies without IACUC approval will be automatically rejected.
Yes
Please indicate which methods were used in your research:
Functional MRI
For human MRI, what field strength scanner do you use?
3.0T
Provide references using APA citation style.
not applicable
No